. . . . . . . "[These results suggested that anti-miR-33a inhibit activation and extracellular matrix production, at least in part, via the activation of PI3K/Akt pathway and PPAR-? and anti sense of miR-33a may be a novel potential therapeutic approach for treating hepatic fibrosis in the future.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:25+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .